London-based Imperial College scientists have mentioned that they are immunizing hundreds of people in an early trial with an experimental coronavirus vaccine after witnessing no panicking safety issues in a small number of vaccinated so far.
To The Associated Press, Imperial College professor Dr. Robin Shattock said that he and his colleagues had just completed a very slow and challenging testing process of the vaccine. For the initial participants, a low dose of vaccine would extend the vaccine trials to around 300 people, including some people of 75+ age.
It’s well-tolerated, and there are no side effects, Dr. Robin Shattock added that its study is still early. Dr. Shattock is the lead of vaccine research. Alongside this, he also said he hopes to have enough safety data to begin immunization on several thousand people in October.
Since COVID-19 infections have curbed dramatically in Britain, so it has made the situation very difficult to decide if the vaccine works or not. However, Shattock said he and his colleagues are also seeking to test their vaccine somewhere else.
They are looking very keenly at the pandemic, especially at the numbers where the hot spots are and in talks to collaborators that have the facilities to do these types of studies, Dr. Robin Shattock said.
The Imperial College vaccine makes use of synthetic strands of genetic code, which are virus-based. When the vaccine is injected into a muscle, the body’s own cells are commanded to create copies of a spiky protein on the coronavirus. In turn, this triggers an immune response so the body could fight off any recurring COVID-19 infection.
In the US, the world’s biggest coronavirus vaccine study begins early this week. The US National Institutes of Health and Moderna Inc. has created the first of 30,000 planned volunteers to get immunized with shots.
A lot of other vaccines developed by Oxford University of Britain and China, based on various vaccine technologies, started smaller final-stage tests in Brazil and several other hard-hit countries earlier July.
The World Health Organization has declared that several vaccine approaches are required for COVID-19, stating that vaccine development's general success rate is around 10%.
Dr. Shattock said that there were several coronavirus vaccines currently in clinical trials, and he also predicted that at least a few of them would prove to be effective.
They have 20 vaccines in clinical trials, so they are pretty confident that at least 2 of those would work. It all depends on the strength of the immune response requires to provide protection, Shattock said. He was optimistic that the Imperial vaccine would work; however, he must wait for the trial's scientific data. He is just going to hold his breath and wait to see the results, Shattock added.
Your rate 3 stars is recorded
StartupWorld is the destination to learn about new and upcoming startups making waves on the web. Being an entrepreneur is as much hard work as it is fun. No one knows it better than you do. Share your story, send it in and let us showcase it to the world.